Logo image of RGC

REGENCELL BIOSCIENCE HOLDING (RGC) Stock Analyst Earnings Estimates

NASDAQ:RGC - Nasdaq - KYG7487R1002 - Common Stock - Currency: USD

4.5  +0.4 (+9.76%)

After market: 4.19 -0.31 (-6.89%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023
Revenue
YoY % growth
RGC revenue by date.RGC revenue by date.
EBITDA
YoY % growth
RGC ebitda by date.RGC ebitda by date.
-390K-800K
-105.13%		-1.35M
-68.75%		-7.47M
-453.33%		-5.98M
19.95%
EBIT
YoY % growth
RGC ebit by date.RGC ebit by date.
-390K-810K
-107.69%		-1.38M
-70.37%		-7.62M
-452.17%		-6.27M
17.72%
Operating Margin
RGC operating margin by date.RGC operating margin by date.
N/AN/AN/AN/AN/A
EPS
YoY % growth
RGC eps by date.RGC eps by date.
N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
RGC Yearly EPS VS EstimatesRGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
RGC Yearly Revenue VS EstimatesRGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A